Citigroup Raises H.B. Fuller (NYSE:FUL) Price Target to $72.00

H.B. Fuller (NYSE:FUL – Get Rating) had its target price upped by Citigroup from $65.00 to $72.00 in a research report report published on Monday morning, The Fly reports.

Several other brokerages have also recently weighed in on FUL. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of H.B. Fuller from $72.00 to $78.00 in a research note on Friday. Robert W. Baird reduced their price objective on shares of H.B. Fuller from $85.00 to $80.00 and set an outperform rating on the stock in a research note on Friday. Finally, StockNews.com assumed coverage on shares of H.B. Fuller in a research note on Wednesday, October 12th. They issued a hold rating on the stock. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, H.B. Fuller presently has an average rating of Hold and an average price target of $70.50.

H.B. Fuller Stock Performance

Shares of H.B. Fuller stock opened at $68.54 on Monday. The company has a quick ratio of 1.14, a current ratio of 1.84 and a debt-to-equity ratio of 1.08. H.B. Fuller has a twelve month low of $57.36 and a twelve month high of $81.41. The stock has a market cap of $3.65 billion, a price-to-earnings ratio of 21.02 and a beta of 1.54. The company’s fifty day moving average is $75.08 and its 200 day moving average is $68.70.

Insider Buying and Selling at H.B. Fuller

In other H.B. Fuller news, VP Heather Campe sold 14,323 shares of the company’s stock in a transaction on Monday, November 14th. The shares were sold at an average price of $75.28, for a total transaction of $1,078,235.44. Following the sale, the vice president now owns 9,100 shares of the company’s stock, valued at $685,048. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other H.B. Fuller news, VP Heather Campe sold 14,323 shares of the company’s stock in a transaction on Monday, November 14th. The shares were sold at an average price of $75.28, for a total transaction of $1,078,235.44. Following the sale, the vice president now owns 9,100 shares of the company’s stock, valued at $685,048. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP James J. East sold 30,384 shares of the company’s stock in a transaction dated Friday, November 11th. The shares were sold at an average price of $75.62, for a total transaction of $2,297,638.08. Following the transaction, the senior vice president now owns 6,590 shares in the company, valued at approximately $498,335.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 200,357 shares of company stock valued at $14,707,214. 4.69% of the stock is currently owned by insiders.

Hedge Funds Weigh In On H.B. Fuller

Institutional investors have recently made changes to their positions in the stock. Eagle Bay Advisors LLC acquired a new position in shares of H.B. Fuller during the second quarter valued at about $33,000. Quantbot Technologies LP acquired a new position in shares of H.B. Fuller during the third quarter valued at about $321,000. Wesbanco Bank Inc. acquired a new position in shares of H.B. Fuller during the fourth quarter valued at about $365,000. AXA S.A. raised its holdings in shares of H.B. Fuller by 37.5% during the third quarter. AXA S.A. now owns 8,800 shares of the specialty chemicals company’s stock valued at $529,000 after purchasing an additional 2,400 shares during the period. Finally, Mutual of America Capital Management LLC raised its holdings in shares of H.B. Fuller by 17.0% in the 2nd quarter. Mutual of America Capital Management LLC now owns 8,910 shares of the specialty chemicals company’s stock worth $536,000 after acquiring an additional 1,297 shares during the last quarter. Institutional investors and hedge funds own 96.53% of the company’s stock.

About H.B. Fuller

(Get Rating)

H.B. Fuller Co engages in the manufacture and marketing of adhesives, sealants, and other specialty chemical products. It operates through the following segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts and envelope markets.